Genetic Stratification of Patients with Parkinson’s Disease
The Rostock International Parkinson's Disease (ROPAD) Study: Protocol and Initial Findings
While Parkinson’s disease (PD) is clinically homogeneous, it can result from a multitude of genetic and non-genetic causes. Stratifying PD patients accordingly is of utmost importance for focused clinical trials, and CENTOGENE is leading the largest corresponding study ever performed. The study’s protocol, along with initial findings, was recently published in Movement Disorders.